Congressman chooses Tarceva over surgery
Executive Summary
Rep. Clay Shaw (R-Fla.) chooses to receive Genentech/OSI's epidermal growth factor receptor inhibitor Tarceva (erlotinib) rather than surgery to treat his lung cancer. Shaw will have surgery during Congress' August recess if Tarceva is ineffective...